✦ LIBER ✦

Phase II Trial of a Doxorubicin/Docetaxel Doublet for Locally Advanced and Metastatic Breast Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Trial BP-57

✍ Scribed by Roy E. Smith; Stewart J. Anderson; Barry C. Lembersky; Ann Brown; Eleftherios P. Mamounas

Book ID: 115075633
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 152 KB
Volume: 5
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2004.n.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Doxorubicin/Docetaxel/

Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58

✍ Roy E. Smith; Stewart J. Anderson; Ann Brown; Aaron P. Scholnik; Ajit M. Desai; 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 118 KB

Pemetrexed/Oxaliplatin for First-Line Tr

Pemetrexed/Oxaliplatin for First-Line Treatment of Patients with Advanced Colorectal Cancer: A Phase II Trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program

✍ James N. Atkins; Samuel A. Jacobs; H. Samuel Wieand; Roy E. Smith; William J. Jo 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Long-term neurotoxicity effects of oxali

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01

✍ Kelley M. Kidwell; Greg Yothers; Patricia A. Ganz; Stephanie R. Land; Clifford Y 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

Cyclophosphamide and liposomal-encapsula

Cyclophosphamide and liposomal-encapsulated doxorubicin (MYOCET®) in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results of a multicenter phase II trial from the Hellenic Oncology Research Group

✍ Karampeazis⁎, A.; Ardavanis, A.; Kentepozidis, N.; Nikolaou, Ch.; Bozionelou, V. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 80 KB

Alternating Systemic and Hepatic Artery

Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

✍ Alberts, S. R.; Roh, M. S.; Mahoney, M. R.; O'Connell, M. J.; Nagorney, D. M.; W 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 105 KB